SCHEMBL23720311

SCHEMBL23720311

O=C1c2ccccc2C(=O)N1CCOCCOCCOCCOCCO

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.54
GAA P10253 1/20 0.51
HPGD P15428 2/20 0.51
NPSR1 Q6W5P4 1/20 0.51
RAB9A P51151 6/20 0.50
NPC1 O15118 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
TSHR P16473 1/20 0.50
MAPT P10636 1/20 0.50
GLA P06280 1/20 0.49
BRCA1 P38398 1/20 0.49
GLS O94925 1/20 0.49
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
HEXA P06865 1/20 0.47
HEXB P07686 1/20 0.47
CASP3 P42574 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26813895 1.00 SMN1; SMN2 (0.54) SMN1; SMN2GAAHPGDNPSR1RAB9A
SCHEMBL26101354 1.00 SMN1; SMN2 (0.54) SMN1; SMN2GAAHPGDNPSR1RAB9A
SCHEMBL30274282 1.00 SMN1; SMN2 (0.54) SMN1; SMN2GAAHPGDNPSR1RAB9A
SCHEMBL30392446 1.00 SMN1; SMN2 (0.54) SMN1; SMN2GAAHPGDNPSR1RAB9A
SCHEMBL30392640 1.00 SMN1; SMN2 (0.54) SMN1; SMN2GAAHPGDNPSR1RAB9A
SCHEMBL3892107 1.00 SMN1; SMN2 (0.54) SMN1; SMN2GAAHPGDNPSR1RAB9A
SCHEMBL19541802 1.00 SMN1; SMN2 (0.54) SMN1; SMN2GAAHPGDNPSR1RAB9A
SCHEMBL5371487 1.00 SMN1; SMN2 (0.54) SMN1; SMN2GAAHPGDNPSR1RAB9A
SCHEMBL230525 1.00 SMN1; SMN2 (0.54) SMN1; SMN2GAAHPGDNPSR1RAB9A
SCHEMBL30274320 0.98 SMN1; SMN2 (0.55) SMN1; SMN2GAAHPGDNPSR1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4423086-A1 TYK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-09-04 EP disclosed
WO-2023076161-A1 TYK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-05-04 WO disclosed
WO-2023076161-A1 TYK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-05-04 WO disclosed
WO-2021155006-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASES AND USES THEREOF LES LABORATOIRES SERVIER SAS (FR) 2021-08-05 WO disclosed